WEKO3
アイテム
{"_buckets": {"deposit": "aa8db35a-1e59-4374-a09d-fbb5d3c54a32"}, "_deposit": {"created_by": 1, "id": "54396", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "54396"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00054396", "sets": ["2"]}, "author_link": ["555624", "555621", "555623", "555622", "555628", "555630", "555627", "555631", "555632", "555625", "555626", "555629"], "item_10003_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2011", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "2", "bibliographicPageStart": "S331", "bibliographicVolumeNumber": "82", "bibliographic_titles": [{"bibliographic_title": "International Journal of Radiation Oncology Biology Physics"}]}]}, "item_10003_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Purpose/Objective(s):Complete surgical resection is the only curative treatment for pancreatic cancer. Even if a curative resection is performed, the disease usually recurs, and the half of the failure pattern is local recurrence. We examined the effect of short course preoperative carbon-ion radiotherapy (CIRT) in terms of reducing the rate of local recurrence in patients undergoing resection for adenocarcinoma of the pancreas.\nMaterials/Methods: Patients with radiographically resectable pancreatic cancer were enrolled from October 2003 to July 2010. Eligibility included no CT involvement of celiac artery or SMA; adequate renal, hepatic and hematopoietic function; and ECOG PS 0-2. CIRT was given once daily, 4 days a week, for a fixed 8 fractions in 2 weeks. The dose was set to 30.0GyE and escalated to 36.8GyE at 5% increments with 5 levels. Treatment volumes included the location of the primary tumor and regional lymph nodes and retroperitoneal area. Surgery was performed 2-4 weeks after completion of CIRT.\nResults: Twenty-eight patients were enrolled on study. Twenty-five patients are eligible for this analysis. Five patients were treated at each of dose levels 1-2. Three patients were at dose level 3. Six patients were at each of dose levels 4-5. Twenty-one patients (84%) underwent resection. Reasons for no resections were: metastatic disease-3 and refusal-1 those were at dose levels 1-2. Although grade 3/4 toxicities were noted in 2 patients (liver abscess-1, PV thrombus-1), both of them were unrelated directly to CIRT. Median follow-up time is 13.9 months (range, 3.2-73.1). There has been on local failure in postoperative patients. Metastatic failure has occurred in 17 out of 25 patients (68%). Five-year survival rates in all patients and postoperative patients are 39% and 48%, respectively.\nConclusions: Short course preoperative CIRT seems to be a safe and effective modality in the management of resectable pancreatic cancer, providing satisfactory local control and offering a survival advantage without unacceptable morbidity.", "subitem_description_type": "Abstract"}]}, "item_10003_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0360-3016", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Shinoto, Makoto"}], "nameIdentifiers": [{"nameIdentifier": "555621", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamada, Shigeru"}], "nameIdentifiers": [{"nameIdentifier": "555622", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yasuda, Shigeo"}], "nameIdentifiers": [{"nameIdentifier": "555623", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Imada, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "555624", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kamada, Tadashi"}], "nameIdentifiers": [{"nameIdentifier": "555625", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsujii, Hirohiko"}], "nameIdentifiers": [{"nameIdentifier": "555626", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "篠藤 誠", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "555627", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "山田 滋", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "555628", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "安田 茂雄", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "555629", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "今田 浩史", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "555630", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鎌田 正", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "555631", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻井 博彦", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "555632", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference paper", "resourceuri": "http://purl.org/coar/resource_type/c_5794"}]}, "item_title": "Efficacy and Safety of Short Course Carbon-ion Radiotherapy for Patients with Preoperative Pancreatic Cancer", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Efficacy and Safety of Short Course Carbon-ion Radiotherapy for Patients with Preoperative Pancreatic Cancer"}]}, "item_type_id": "10003", "owner": "1", "path": ["2"], "permalink_uri": "https://repo.qst.go.jp/records/54396", "pubdate": {"attribute_name": "公開日", "attribute_value": "2013-11-14"}, "publish_date": "2013-11-14", "publish_status": "0", "recid": "54396", "relation": {}, "relation_version_is_last": true, "title": ["Efficacy and Safety of Short Course Carbon-ion Radiotherapy for Patients with Preoperative Pancreatic Cancer"], "weko_shared_id": -1}
Efficacy and Safety of Short Course Carbon-ion Radiotherapy for Patients with Preoperative Pancreatic Cancer
https://repo.qst.go.jp/records/54396
https://repo.qst.go.jp/records/54396de09f6e1-e339-4135-b882-3267a9b1dea0
Item type | 会議発表論文 / Conference Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2013-11-14 | |||||
タイトル | ||||||
タイトル | Efficacy and Safety of Short Course Carbon-ion Radiotherapy for Patients with Preoperative Pancreatic Cancer | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_5794 | |||||
資源タイプ | conference paper | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Shinoto, Makoto
× Shinoto, Makoto× Yamada, Shigeru× Yasuda, Shigeo× Imada, Hiroshi× Kamada, Tadashi× Tsujii, Hirohiko× 篠藤 誠× 山田 滋× 安田 茂雄× 今田 浩史× 鎌田 正× 辻井 博彦 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Purpose/Objective(s):Complete surgical resection is the only curative treatment for pancreatic cancer. Even if a curative resection is performed, the disease usually recurs, and the half of the failure pattern is local recurrence. We examined the effect of short course preoperative carbon-ion radiotherapy (CIRT) in terms of reducing the rate of local recurrence in patients undergoing resection for adenocarcinoma of the pancreas. Materials/Methods: Patients with radiographically resectable pancreatic cancer were enrolled from October 2003 to July 2010. Eligibility included no CT involvement of celiac artery or SMA; adequate renal, hepatic and hematopoietic function; and ECOG PS 0-2. CIRT was given once daily, 4 days a week, for a fixed 8 fractions in 2 weeks. The dose was set to 30.0GyE and escalated to 36.8GyE at 5% increments with 5 levels. Treatment volumes included the location of the primary tumor and regional lymph nodes and retroperitoneal area. Surgery was performed 2-4 weeks after completion of CIRT. Results: Twenty-eight patients were enrolled on study. Twenty-five patients are eligible for this analysis. Five patients were treated at each of dose levels 1-2. Three patients were at dose level 3. Six patients were at each of dose levels 4-5. Twenty-one patients (84%) underwent resection. Reasons for no resections were: metastatic disease-3 and refusal-1 those were at dose levels 1-2. Although grade 3/4 toxicities were noted in 2 patients (liver abscess-1, PV thrombus-1), both of them were unrelated directly to CIRT. Median follow-up time is 13.9 months (range, 3.2-73.1). There has been on local failure in postoperative patients. Metastatic failure has occurred in 17 out of 25 patients (68%). Five-year survival rates in all patients and postoperative patients are 39% and 48%, respectively. Conclusions: Short course preoperative CIRT seems to be a safe and effective modality in the management of resectable pancreatic cancer, providing satisfactory local control and offering a survival advantage without unacceptable morbidity. |
|||||
書誌情報 |
International Journal of Radiation Oncology Biology Physics 巻 82, 号 2, p. S331, 発行日 2011 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0360-3016 |